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Abstract
Wasting and stunting are often presented as two separate 
forms of malnutrition requiring different interventions 
for prevention and/or treatment. These two forms of 
malnutrition, however, are closely related and often 
occur together in the same populations and often in the 
same children. Wasting and stunting are both associ-
ated with increased mortality, especially when both 
are present in the same child. A better understanding 
of the pathophysiology of these two different forms of 
malnutrition is needed to design efficient programs. A 
greatly reduced muscle mass is characteristic of severe 
wasting, but there is indirect evidence that it also occurs 
in stunting. A reduced muscle mass increases the risk of 
death during infections and also in many other differ-
ent pathological situations. Reduced muscle mass may 
represent a common mechanism linking wasting and 
stunting with increased mortality. This suggests that to 
decrease malnutrition-related mortality, interventions 
should aim at preventing both wasting and stunting, 
which often share common causes. Also, this suggests that 
treatment interventions should focus on children who are 
both wasted and stunted and therefore have the greatest 
deficits in muscle mass, instead of focusing on one or the 
other form of malnutrition. Interventions should also 
focus on young infants and children, who have a low 
muscle mass in relation to body weight to start with. 
Using mid-upper-arm circumference (MUAC) to select 
children in need of treatment may represent a simple way 
to target young wasted and stunted children efficiently 
in situations where these two conditions are present. 
Wasting is also associated with decreased fat mass. A 
decreased fat mass is frequent but inconsistent in stunt-
ing. Fat secretes multiple hormones, including leptin, 
which may have a stimulating effect on the immune 
system. Depressed immunity resulting from low fat stores 
may also contribute to the increased mortality observed 
in wasting. This may represent another common mecha-
nism linking wasting and stunting with increased mortal-
ity in situations where stunting is associated with reduced 
fat mass. Leptin may also have an effect on bone growth. 
This may explain why wasted children with low fat stores 
have reduced linear growth when their weight-for-height 
remains low. It may also explain the frequent association 
of stunting with previous episodes of wasting. Stunting, 
however, can occur in the absence of wasting and even in 
overweight children. Thus, food supplementation should 
be used with caution in populations where stunting is not 
associated with wasting and low fat stores. 
Introduction
The terms wasting and stunting were introduced in the 
early 1970s by John Waterlow to differentiate, among 
underweight children, those who had a low weight in 
relation to their height (wasted) from those who were 
small for their age (stunted) [1–3]. Based on clinical 
experience, he considered that wasted children were 
more at risk than stunted children and that children 
who were both wasted and stunted were the most at 
risk [4]. 
The terms “acute” and “chronic” malnutrition are 
often used to describe wasting and stunting, respec-
tively. Although it is generally true that wasting is a 
more transient form of malnutrition [5], these terms 
may be misleading. Both moderate and severe wast-
ing, if untreated, can last several months [6, 7], which 
does not correspond to the usual meaning of “acute.” 
And whereas becoming stunted, i.e., having a height/
length-for-age z-score < –2, may take several months, 
the process of stunting, i.e., having a suboptimal linear 
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growth [8], can start immediately in response to an 
acute stress. The term “severe acute malnutrition” 
(SAM), which also includes edematous malnutrition, 
however, is widely used and has been endorsed by a 
UNICEF/ World Health Organization (WHO) Joint 
Statement [9].
The relationship and associations between wasting 
and stunting are not yet well understood. Both forms 
of malnutrition probably share many causal pathways, 
as an extensive review of the literature failed to identify 
risk factors for wasting not associated with stunting 
[10]. At the population level, the frequency of stunting 
in the age group from 18 to 24 months is correlated 
with that of wasting in children less than 17 months of 
age [5]. These two forms of malnutrition are unques-
tionably linked, but the direct relationship between 
them has not been elaborated. 
In this paper we review the similarities and differ-
ences in the pathophysiology of wasting and stunting 
and their relationship, and discuss the implications for 
programs and policy. 
Pathophysiology of wasting and stunting 
Changes in body composition during malnutrition
When energy intake is insufficient to sustain metabo-
lism, different physiological adjustments take place 
to ensure that key organs have adequate fuel supply 
by drawing on the body’s nutritional reserves, mainly 
fat and muscle [11]. If food deprivation is sustained 
and occurs during the growth period, animal models 
suggest that major changes in relative organ size take 
place, sparing the brain but affecting the heart, kidney, 
thymus, and especially the muscles, with possible long-
term consequences even during adult life [12]. These 
adjustments follow rapid changes in insulin and gluca-
gon levels and include both short-term and long-term 
regulation of key enzymes, putting the organism in an 
energy-sparing mode. 
During acute malnutrition in the absence of infec-
tion, metabolism is sustained mainly by mobilizing 
fat stores, with most organs getting the energy they 
need from fatty acid catabolism. Most fatty acids do 
not cross easily the blood-brain barrier, however, and 
the brain usually gets most of its energy from glucose. 
After a few days of insufficient energy intake, the brain 
shifts to also using water soluble ketone bodies, which 
are also derived from fatty acid catabolism. This shift 
toward ketone bodies occurs earlier in children than 
in adults, presumably because of the higher relative 
brain mass of children, with a high glucose demand in 
relation to body weight. Even with the increasing use of 
ketone bodies, the brain (and red cells) continue to use 
glucose, which is produced from the glycerol derived 
from triglycerides, but also by the liver and kidney 
from amino acids (alanine and glutamine) released 
from muscle. Amino acids from muscle are also needed 
to sustain protein metabolism when protein intake is 
insufficient (which usually goes hand in hand with 
deficient energy intake). But in the absence of infection, 
only a minimal level of protein catabolism is required 
to fulfill glucose and protein needs, muscle mass loss 
is minimal, and the organism lives mainly on body 
fat stores. In this situation, death occurs when the fat 
reserve is exhausted [11].
During infection, there is an added double nutri-
tional stress. First, food intake is typically reduced as 
a result of anorexia, and second, there is an increased 
demand for amino acids for the accelerated synthesis 
of acute phase proteins, for the production of glu-
tathione, and for building up the adaptive immune 
response. These reactions to infection have a negative 
effect on nitrogen balance (even when dietary intake 
is adequate), which leads to the mobilization of amino 
acids from lean tissues, mainly from muscle [13]. 
The body’s response to a range of aggression can also 
shed light on the body’s response to restricted dietary 
intake and infection. Conditions as different as burns, 
sepsis, and cancer are also associated with the mobiliza-
tion of amino acids from muscle by mechanisms that 
are the same as those involved in responses to insuf-
ficient energy intake and infection [14]. Inflammation 
can lead to the development of insulin resistance, also 
contributing to a reduction of nutrients available for 
muscle metabolism [15]. When infection or inflamma-
tion is associated with a poor-quality diet and insuffi-
cient nutrient intake, these effects reinforce each other, 
which leads to a rapid deterioration of muscle mass. 
In summary, the metabolic adjustments taking 
place during malnutrition lead to a decrease in fat and 
muscle masses, the latter being more important when 
there is associated inflammation or infection. These 
changes in body composition, which are indirectly 
reflected by anthropometric indices of wasting and 
stunting, have important functional implications. 
Decreased muscle mass in wasting and stunting—a 
plausible common link with increased mortality
Wasting and stunting have long been known to be 
associated with an increased risk of death [16, 17], but 
the mechanisms of this association are rarely discussed. 
Anthropometric indices of wasting and stunting meas-
ure a statistical deviation of body size from a standard. 
A direct link between these anthropometric indices and 
mortality would suppose that the organism is able to 
assess this deviation. However, the existence of a central 
“sizostat” allowing the organism to compare its current 
size with a theoretical value, postulated in 1963 by 
Tanner [18], has not been confirmed by experimental 
evidence and now seems very unlikely [19]. The exist-
ence of a physiological change related to this difference 
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expressed in standard deviations of the growth stand-
ards seems even less plausible. Hence, z-scores for 
weight-for-height and height-for-age (indices of wast-
ing and stunting, respectively) should be considered as 
statistical concepts with no clear link with physiological 
changes, and their association with mortality should be 
considered as indirect and noncausal. 
In his early papers, Waterlow speculated that chil-
dren with wasting have an alteration of body com-
position [1]. Forty years later, the most compelling 
explanation of the association of wasting and stunting 
with mortality is indeed that wasting and stunting 
reflect changes in body composition, in particular a 
decrease in muscle and fat mass, which, if severe, com-
promise the provision of fuel to vital organs, such as the 
heart, kidney, liver, immune system, and gut, especially 
when infection is also present. 
In clinical settings, muscle mass is a major determi-
nant of survival in malnourished adult patients with 
infections [20] and also in conditions as diverse as liver 
transplantation [21], liver cirrhosis [22], cancer [23, 
24], and chronic obstructive pulmonary disease [25, 
26]. Studies in these patients consistently show that 
those with a high muscle mass have better survival, 
independently of their body mass index. 
Children have a lower muscle mass in relation to 
body weight than do adults. This effect is difficult to 
quantify, as muscle mass cannot be measured reliably 
in infants and young children, but it is undoubtedly 
present, as postmortem studies show that muscle mass 
represents only 23% of body mass in newborns, versus 
43% in adults [27]. Also, in children, the brain, with 
its high demand for glucose, has a size in relation to 
body weight that is unprecedented in the history of 
evolution. Since a large proportion of glucose is derived 
from amino acids derived from muscle, an effect of 
low muscle mass on survival is even more likely for 
children than for adults. This is also suggested by epi-
demiological studies linking indices of muscularity at 
the arm level with the risk of death in contexts where 
the association between infection and malnutrition is 
a major cause of death [28, 29].
Despite the importance of muscle mass as a determi-
nant of survival in the association between malnutri-
tion and infection, and the visible muscle wasting seen 
in children with SAM, the decrease of muscle mass in 
child malnutrition has hardly been measured. Those 
studies which have been done took place in the 1970s. 
Limitations in the application of methods to measure 
muscle mass in children are one reason for this lack of 
data. Among modern methods used to measure muscle 
mass, imaging techniques require expensive equipment 
and expose children to undesirable doses of x-rays. 
These techniques also require that the patient remain 
still for a few minutes, which is difficult to obtain in 
young children. Segmental bioimpedance analysis, 
which does not rely on x-rays, also requires the patient 
to remain still and so far has not been applied to young 
children [30].
Dilution of 15N-labeled creatine, the most reliable 
method to measure muscle mass, has been used in 
only seven children with SAM compared with eight 
controls (often the same children) at recovery [31]. In 
this sample of wasted children with an average weight-
for-height of 70%, the muscle mass was only 49% of 
the level expected for their height, showing that loss 
of muscle mass is disproportionately high in severely 
wasted children. Measurement of urinary 3-methyl his-
tidine secretion is an indirect marker of muscle mass. 
Its measurement in children with SAM also suggests 
a drastic reduction of muscle mass in relation to body 
weight to less than one-third of that in well-nourished 
children [32]. These measurements also indicate that 
the relationship between creatinine and 3-methyl 
histidine excretion is altered in children with SAM, 
suggesting an abnormal muscle tissue composition. 
This is consistent with major histological changes in 
muscle tissue observed in malnourished children, with 
a decreased proportion of myogenic cells compared 
with vascular, nerve, and interstitial cells [33]. 
There are even fewer data on the body composition 
and muscle mass of stunted children. Indirect evidence 
suggests that muscle mass is also reduced in relation to 
body weight in stunted children, although the absence 
of clinically visible muscle wasting suggests that it is less 
pronounced than in wasting. Muscle is located mainly 
in the limbs, and the muscle arm area or circumfer-
ence can be considered as a proxy estimate of muscle 
mass. Muscle arm indices derived from mid-upper-arm 
circumference (MUAC) are related to height-for-age 
[34–36]. Arm and leg lengths are also likely to be deter-
minants of muscle mass, and a reduced limb length 
may lead to decreased muscle mass in the stunted 
child. Both arm and leg lengths seem to be reduced 
in relation to total body length during stunting [37]. 
Epidemiological studies show that the length deficit 
predominates in the legs during stunting, presumably 
because growth retardation usually occurs during the 
first 2 years of life at an age where linear growth pre-
dominates in the lower part of the body [38]. 
The presence of low muscle mass in both wasting 
and stunting and the link between muscle mass and 
survival in a wide range of clinical conditions suggest 
that both wasting and stunting could increase the 
risk of death through a decreased muscle mass. Both 
conditions are associated with increased mortality, 
especially when they are severe: the mortality associ-
ated with severe stunting is higher than that associated 
with moderate wasting. The greater decrease in muscle 
mass associated with wasting could explain the higher 
risk of death associated with wasting compared with 
stunting (fig. 1) [17]. A common mechanism involving 
a reduced muscle mass (through limbs being both thin-
ner and shorter in wasting and stunting, respectively) 
S18 A. Briend et al.
would also explain why the risk of death is considerably 
increased when wasting and stunting are both present 
in the same child [39] (fig. 2). If malnutrition is sus-
tained and is associated with changes in relative organ 
weights and reduced function of key organs, such as 
the heart, kidney, and immune system, this can also 
compound the effect of the lack of fuel resulting from 
low muscle mass during an acute food shortage.
An effect of wasting and stunting on mortality 
through reduced muscle mass suggests that young 
infants and children are especially vulnerable to 
malnutrition because they have a low muscle mass in 
relation to body weight, even in the absence of malnu-
trition as mentioned above. 
Fat mass in wasting and stunting: Effect on mortality
Fat stores are deeply depressed in cases of wasting 
[3]. The effect of stunting on fat reserves is not so 
clear. Lower skinfold thickness or body fatness has 
been reported in stunted children [36, 40] but stunted 
children can also be overweight in terms of weight-
for-height [41], suggesting they may also have excess 
body fat. 
As noted above, in the absence of infection, fat is 
the main fuel for the organism in case of insufficient 
energy intake, and survival can therefore be linked to 
fat mass [11]. Fat, and especially central fat, can also 
play a role in maintaining the immune system, which is 
energy demanding when stimulated [42]. Leptin, which 
is produced by adipocytes and reflects body fat stores, 
may have a stimulating effect on the immune system 
by increasing cytokine and lymphocyte secretion [43, 
44]. Thus, fat can also be linked to survival through an 
effect on the immune system. In this regard, a recent 
study has shown that leptin levels are linked to survival 
in children with SAM treated in the hospital [45]. 
Thus, fat depletion could also provide an additional 
common mechanism linking wasting and stunting with 
increased mortality in situations where stunting is asso-
ciated with low fat stores. A study in Senegal, however, 
failed to find an independent association between arm 
skinfold thickness and survival [28]. 
Possible direct link between wasting and stunting
Children with severe wasting are often stunted, sug-
gesting that wasting and stunting have a common cause 
or that one form of malnutrition can contribute to the 
development of the other. That wasting may be a cause 
of stunting is supported by two studies examining the 
growth pattern of children recovering from SAM. The 
first study showed that among children with SAM who 
had linear catch-up growth, two-thirds started to grow 
only after reaching a weight-for-height of at least 85% 
of the National Center for Health Statistics (NCHS) 
median [46]. The other study indicated that during 
SAM treatment, linear growth accelerated as weight-
for-height increased, without a clear threshold above 
which growth resumed [47]. Both studies suggest that 
growth in height takes place only when the body has 
a minimum of energy reserves. This is also consistent 
with seasonal changes in growth in height and weight, 
which take place at different times of the year in com-
munities with varying food availability, where children 
appear to grow in height only when their weight-for-
height is high at the beginning of the season [48, 49]. 
A similar association between initial weight-for-height 
FIG. 1. Risk of death associated with wasting and stunting. 
The larger increase in mortality observed with wasting can be 
explained by the more important muscle and fat loss observed 
in wasting. Source: adapted from Olofin et al. [17]
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FIG. 2. Combined effects of wasting and stunting on mortal-
ity. The risk of dying increases dramatically when wasting 
and stunting are present at the same time. This interaction is 
in favor of a common mechanism linking wasting and stunt-
ing with an increased risk of death. Low muscle mass, which 
is present in both forms of malnutrition and known to be 
associated with increased mortality in a wide range of clinical 
conditions, could be this common mechanism. Low fat mass 
could be an additional effect in situations where it is associ-
ated with stunting. Source: adapted from McDonald et al. [39]
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and growth in length in the following months, without 
a threshold effect, has also been reported in cohorts 
with a very low prevalence of wasting [50, 51]. A recent 
review of the association between wasting and stunting 
showed that wasting after 6 months of age is associated 
with a lower attained length-for-age at 17 months [5].
These observations may be explained by the role 
of fat in regulating bone mass and linear growth [51]. 
Recent advances suggest that fat and bones can both 
be regarded as endocrine organs secreting hormones 
and interacting with each other and with other organs, 
including the brain. Fat tissues produce leptin, which 
has an influence on bone density and catch-up growth 
[52, 53]. A study in moderately wasted children sug-
gests that catch-up growth in length takes place only in 
children with a increase in leptin concentration [54]. 
These early findings need confirmation in children 
recovering from SAM and also in moderately wasted 
children, but they suggest that wasting associated with 
low fat stores and low leptin levels may halt linear 
growth and may prevent linear catch-up growth if 
untreated. Clinical observations of two children with 
congenital leptin deficiency and normal linear growth 
[55] suggest, however, that other factors beyond leptin 
are important in regulating linear growth. 
The possible link between low fat stores, often associ-
ated with wasting, and linear growth and the existence 
of a plausible mechanism to explain this association do 
not imply that wasting is the major cause of stunting. 
Other mechanisms causing stunting can be involved, 
and high levels of stunting prevalence can be observed 
in populations where wasting is uncommon [3, 56]. A 
recent review of eight community studies examining 
growth longitudinally suggests that, despite the link 
between periods of wasting and subsequent stunting, 
stunting is far more common than the prevalence of 
earlier wasting can explain [5]. Also, low birthweight 
explains part of stunting prevalence independently of 
wasting [57].
The long-term effect on stunting of repeated epi-
sodes of weight loss has also been extensively exam-
ined in the context of repeated episodes of diarrhea. 
The available evidence suggests that in these children, 
weight loss related to diarrheal episodes is transient and 
is followed by catch-up growth, and that its long-term 
effect on linear growth explains only a small part of the 
observed stunting [58]. A link between environmental 
enteropathy and linear growth, however, seems plau-
sible [59].
Stunting can coexist with a high overweight preva-
lence in some populations [41]. This suggests that if 
high fat stores are needed to promote linear growth, 
they are not sufficient. Sulfur, phosphorus, calcium, 
magnesium, vitamins D, K, and C, and copper are 
nutrients that are required in higher amounts for skel-
etal growth than for growth of other lean tissues [60]. 
Insufficient intake of these nutrients may explain a high 
prevalence of stunting in the absence of wasting. A low 
intake of nutrients needed for bone growth and lean 
tissue synthesis may explain the possible association 
of stunting with reduced muscle mass and normal or 
even increased fat reserves. This possible mechanism 
is supported by the observation that diets with insuf-
ficient zinc content are associated with low height gains 
and excess fat deposition during catch-up growth of 
children with SAM [61]. 
Policy and programmatic implications of 
the similarities and interactions between 
wasting and stunting
Interventions should be targeted as a priority to chil-
dren who have a high risk of death and also to those 
who have a high probability of responding to treatment. 
Accepting that wasting and stunting increase the risk 
of death through common mechanisms and are inter-
related has implications for selecting interventions 
based on these two criteria. This suggests that there 
is no strong rationale for different interventions for 
these two forms of malnutrition, except in situations 
where stunting occurs in the absence of wasting and is 
associated with normal fat stores. 
Selecting children at high risk 
Considering wasting and stunting as two separate 
conditions can lead to misguided decisions, as this 
approach neglects the fact that they can occur simul-
taneously in the same individual and that there are 
important interactions between these two conditions. 
In particular, focusing interventions to reduce mortal-
ity on wasted children on the assumption that they have 
an “acute” malnutrition will miss quite a few severely 
stunted children who have a higher risk of death than 
do moderately wasted children. Accepting common 
mechanisms for the association between wasting and 
stunting and the increased risk of death suggests that 
the correct approach would be not to just select chil-
dren who are wasted or stunted for intervention, but 
to prioritize those who are both wasted and stunted. 
If low muscle mass is the main common factor 
increasing the risk of death in wasted and stunted 
children with associated infections, age should also be 
considered as an additional risk factor, as muscle mass 
is proportionally lower in younger children. Selecting 
young wasted and stunted children may seem a chal-
lenge, as this implies combining with adequate weight-
ing factors two indices that themselves are composite 
variables (weight-for-height and height-for-age), with 
an additional unknown correction factor related to 
age to take into account the lower muscle mass of 
young children. This objective, however, is likely to be 
achieved in a simple way by using MUAC unadjusted 
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for age as the admission criterion for treatment pro-
grams, an approach that is currently endorsed by WHO 
[9] and that in fact does select young children with a 
low weight-for-height and a low height-for-age with the 
highest risk of death [62–64]. Correction of MUAC for 
age or height does not improve the estimation of the 
risk of death [65, 66]. The limited current evidence 
suggests that MUAC is at least as good as weight-for-
height and height-for-age for estimating muscle and 
fat mass in relation to body weight in children [67]. 
Children with low MUAC should be the priority target, 
independently of their respective degree of wasting 
or stunting as defined by their weight-for-height and 
height-for-age. 
The effect of young age on muscle mass suggests also 
that malnourished children under 6 months of age, par-
ticularly children born small for gestational age, who 
are often neglected in current programs, should be a 
primary target of programs aiming at preventing death.
Identifying children who will benefit from 
interventions
Preventive interventions
The immediate underlying and basic causes of mal-
nutrition seem to be common to both wasting and 
stunting [10]. Accepting that wasting and stunting 
act through a common mechanism suggests that any 
intervention that is designed to have an effect on one 
form of malnutrition should also have an effect on the 
mortality risk associated with the other. Thus, there 
is a clear rationale for designing and implementing 
programs to simultaneously prevent both forms of mal-
nutrition in those regions and countries (the majority) 
where both wasting and stunting are prevalent. 
In contexts where stunting exists in the absence of 
wasting, and more specifically when stunting is not 
associated with low body fat stores, programs aiming 
specifically at stunted children are warranted. Argu-
ably, this is the only situation where separating these 
two forms of malnutrition has a strong rationale. Food 
supplementation programs should be used carefully in 
these situations because they may increase the preva-
lence of overweight if given indiscriminately [68]. The 
food supplements, where used, should be carefully 
formulated to ensure that key nutrients for lean tissue 
synthesis and bone growth are included to avoid excess 
fat deposition [60]. 
Therapeutic intervention
There is ample evidence that wasted children put on 
weight (mainly muscle and fat) very rapidly when 
fed an adequate energy- and nutrient-dense diet and 
infection is treated [3, 69, 70]. Assuming that low 
muscle and fat mass increases the risk of death, current 
treatment is likely to highly benefit wasted children. 
Treatment of wasting with ready-to-use therapeutic 
food (RUTF) has a limited effect on stunting during 
the catch-up phase [71]. The increase in muscle mass 
obtained by treating the associated wasting should, 
however, benefit stunted children, assuming that the 
reduced muscle mass is the main risk factor increasing 
mortality in stunted children. 
The low fat mass observed in wasted children and in 
some stunted children also suggests that the increase 
in fat mass taking place when associated wasting is 
corrected will potentially benefit stunted children 
who have a low fat mass to start with. This will result 
in an increased hormone production from adipocytes, 
in particular of leptin, which will stimulate immunity 
and linear growth.
Research gaps
The relationship between wasting and stunting and 
their functional consequences is still poorly under-
stood. Although a coherent plausible picture emerges 
from our current knowledge, there remain evidence 
gaps and mechanisms that require confirmation.
» Changes in body composition, in particular in 
muscle mass and fat mass, and their relationship to 
anthropometric indicators and functional outcomes 
should be better explored in wasted and stunted 
children. 
» The relationship between fat stores and stunting and 
the possible role of leptin should be explored. This 
should help to clarify the need to increase energy 
intake in stunted populations, finding the balance 
between ensuring a minimum fat store to promote 
linear growth and avoiding giving too much energy 
and thus exposing children to the risk of becoming 
overweight. 
» Response to treatment, and in particular changes in 
height and body composition in response to supple-
mentation in wasted and stunted children, should be 
better described.
» In high-burden contexts, case studies are needed 
where joint wasting and stunting prevention and 
linked treatment programs are implemented. These 
should explore the policy and programmatic lessons 
from linking wasting and stunting and, in particular, 
clear monitoring of outcomes.
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